Bonnie Donato

Company: Boehringer Ingelheim

Job title: Executive Director – Value & Access, HEOR CRM

Seminars:

Panel Discussion – Harnessing Real-World Data to Evaluate Coverage Criteria & Consider the Current Clinical Management Strategies for Obesity & Related Conditions 10:00 am

Reviewing the current coverage for obesity treatments including lifestyle interventions, medication, and surgery to uncover limitations and inconsistencies Discussing the need to move beyond simple cost-effectiveness analysis and leveraging RWD to assess the broader value of obesity treatments such as long-term health outcomes Addressing comorbidities to highlight the importance of considering related conditions and using…Read more

day: Conference Day One

Roundtable Discussion – Effectively Integrating Real-World Evidence for Holistic Obesity Management to Improve Value Proposition for Private, Commercial & State Payers 2:30 pm

Predictive Data Modelling to Inform Future Quantifying Return on Investment for Payers Scaling & Sustaining Holistic Obesity ManagementRead more

day: Conference Day One

Understanding the Advantages & Disadvantages of Using Real World Data for the Assessment of Adherence & Persistence with Obesity Medications to Predict Payer Pushback 9:30 am

Discussing the best sources of RWE and HEOR to improve validity and reliability of studies Exploring the advantages of large sample sizes, longitudinal patient journeys and diverse population to gain the most accurate understanding of patient adherence and persistence with obesity medications outside of controlled clinical trial settings Uncover the limitations and potential biases associated…Read more

day: Conference Day Two